News Focus
News Focus
icon url

DorseyE

04/03/05 10:54 AM

#23328 RE: altarboy4 #23297

altarboy40, they are definitely headed that way fast...

According to Dr. Janet Woodcock, Deputy Director for Operations at FDA, "FDA's efforts will bring us one step closer to 'personalizing' medical treatment." She added, "We hope ultimately to bring pharmacogenomics . . . to every healthcare professional's prescription pad for the benefit of their patients and U.S. consumers." Personalized medicine, according to the FDA, will eventually replace "the standard hit-or-miss approach to treating patients."

Soon after the FDA announcement, the Personalized Medicine Coalition (PMC), of which DNAPrint is a member, issued its own release applauding the guidelines as "paving the way to a new generation of diagnostics and therapeutics." The agency noted "that our members are looking forward to additional protocols, specifically those on the co-development of pharmacogenomic diagnostics and therapeutics and on the use of micro-arrays in DNA analysis.

From the vantage point of the future, today's FDA announcement is likely to be regarded as a milestone in drug discovery and development that will help lead to a new generation of medicine and healthcare, that of tailoring treatment to the individual based on his or her genetic and molecular makeup".

icon url

dr frudaky

04/03/05 11:28 AM

#23331 RE: altarboy4 #23297

altarboy4 you have to ask yourself whether or not dnap has anything worth something in personalized medicine. the company cannot seem to get any patents so maybe what it has is not new and valuable. also, no company has come forward to buy or license what dnap has for sale. they all know about dnap and what it has but nobody seems to care.

I think that is why the company cannot get personalized medicine off dead center and now must rely on forensics which is not popular and only produces small revenues. that is also why the pps keeps sinking well into subpenny and will continue to sink further.

you have to ask yourself why with all the articles posted here about how great personalized medicine going to be dnap doesnt seem to have any part of it. if it cannot get on that bandwagon now why would you think it can get on later? there really is nothing new coming out of the company in that area that everybody doesnt already know about. all this is definitely not looking good for the investors, even with all the pumping going on which has no effect in raising the pps.

dr f